Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

marketwatch.com - Ironwood Pharma Promotes Tammi Gaskins to Succeed CEO Tom McCourt
Ironwood Pharma Promotes Tammi Gaskins to Succeed CEO Tom McCourt
MarketWatch –

Ironwood Pharmaceuticals' Chief Commercial Officer Tammi Gaskins has been appointed to succeed Chief Executive Tom McCourt when he retires after 17 years at the biotechnology company. Boston-based Ironwood said Gaskins will step into the role…

marketbeat.com - Ascentage Pharma Group International - Unsponsored ADR (AAPG) - What Are Researchers Thinking About This Stock?
Ascentage Pharma Group International - Unsponsored ADR (AAPG) - What Are Researchers Thinking About This Stock?
MarketBeat –

Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) have earned a consensus recommendation of 'Buy' from the fourteen ratings firms that are currently covering the company, MarketBeat reports. Twelve…

marketbeat.com - Royalty Pharma PLC $RPRX Shares Purchased by Triasima Portfolio Management inc.
Royalty Pharma PLC $RPRX Shares Purchased by Triasima Portfolio Management inc.
MarketBeat –

Triasima Portfolio Management inc. raised its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 23.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned…

thenation.com - The Nation - Smoke and Mirrors: The Right's Latest Attacks Against Trans People
Smoke and Mirrors: The Right's Latest Attacks Against Trans People
Home 10/15 | The Nation –

Bluesky In the final weeks of the 2024 election, the refrain “ Kamala is for They/Them, Trump is for You ” blared from TVs in the battleground states during NFL and college-football games. Seeking to capitalize on voters' frustrations…

marketwatch.com - Health Care Down, But not by Much, Amid Defensive Bias -- Health Care Roundup
Health Care Down, But not by Much, Amid Defensive Bias -- Health Care Roundup
MarketWatch –

Health-care companies fell, but not by as much as the broad market, as traders rotated out of the technology sector into defensive areas. Shares of major health insurers such as UnitedHealth gave back some of their gains for the week but remained…

marketwatch.com - Ascendis Gets EMA Recommendation for Approval for Achondroplasia Treatment in Children
Ascendis Gets EMA Recommendation for Approval for Achondroplasia Treatment in Children
MarketWatch –

A committee from the European Medicines Agency recommending granting marketing authorization for Ascendis Pharma's treatment for achondroplasia in children. The EMA's Committee for Medicinal Products for Human Use said Friday that Ascendis's…

thehindubusinessline.com - Editorial. Fatally expensive
Editorial. Fatally expensive
BusinessLine –

Of late, courts have taken a serious view of the astronomical prices of cancer drugs. Responding to the concerns of the Supreme Court — and before that, Kerala High Court — the Centre has said that it will cap the MRP of…

swissinfo.ch - swissinfo.ch - Berlin and Paris open 'Made in Europe' door to Switzerland
Berlin and Paris open 'Made in Europe' door to Switzerland
www.swissinfo.ch –

Switzerland would be treated on an equal footing with the countries of the European Economic Area and the United Kingdom. This is according to a Franco-German position paper published on Thursday, a copy of which has been seen by the Keystone-SDA…

koreatimes.co.kr - Hyun Jin-hyeok - Korea's 1st homegrown obesity drug likely to intensify price competition
Korea's 1st homegrown obesity drug likely to intensify price competition
The Korea Times –

Korea's first homegrown obesity drug could shake up a market dominated by Mounjaro and Wegovy, an industry official said, as more Koreans travel to Japan to obtain cheaper Mounjaro and bring it home illegally, driven by the high cost of obesity…

seekingalpha.com - High Alpha Professor - NGL Energy Partners: Booming Water Business, But Common Units Look Expensive (NYSE:NGL)
NGL Energy Partners: Booming Water Business, But Common Units Look Expensive (NYSE:NGL)
Seeking Alpha –

NGL Energy Partners is rated 'Sell' due to high leverage, preferred obligations, and limited upside at current valuations. Water Solutions drives strong EBITDA margins, but over half of revenue growth is from less predictable recovered crude oil…

seekingalpha.com - Albert Anthony - U.S. Bancorp Upgraded After Stellar Q3, As Commercial And Consumer Credit Demand Shines
U.S. Bancorp Upgraded After Stellar Q3, As Commercial And Consumer Credit Demand Shines
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

rollingstone.com - Daniel Kreps - Method Man Hears Wu-Tang Clan's One-Copy-Only Album for First Time: 'I Don't Hate It
Method Man Hears Wu-Tang Clan's One-Copy-Only Album for First Time: 'I Don't Hate It
Rolling Stone –

Method Man listened to the Wu-Tang Clan 's Once Upon a Time in Shaolin for the first time — and delivered his opinion on the now-infamous, one-copy-only album — on the latest episode of Pablo Torre Finds Out. For years, the story…

billboard.com - Michael Saponara - Method Man Finally Hears Wu-Tang Clan's 'Once Upon a Time in Shaolin' for the First Time: Here's How He Reacted
Method Man Finally Hears Wu-Tang Clan's 'Once Upon a Time in Shaolin' for the First Time: Here's How He Reacted
Billboard –

Method Man recorded and sent in his contributions for Wu-Tang Clan's Once Upon a Time in Shaolin album, but never listened to the completed version of the notorious album, which was recorded from 2007 to 2013. That changed in the Friday (Oct. 16)…

prnewswire.com - Xtalks - Xtalks Named Media Partner for the 2026 CTO Clinical Trials Conference
Xtalks Named Media Partner for the 2026 CTO Clinical Trials Conference
Cision PR Newswire –

The 2026 conference will explore how Canada can strengthen its position in global clinical research, with discussions on improving trial efficiency, integrating research into patient care and expanding access to clinical trials. 'CTO's Clinical…

thehindubusinessline.com - Team BL - Stock Market Highlights, Oct 16: Sensex gains 413 pts, Nifty ends at 23,146 led by IT stocks
Stock Market Highlights, Oct 16: Sensex gains 413 pts, Nifty ends at 23,146 led by IT stocks
BusinessLine –

Sensex Today, Nifty 50 | Stock Market Highlights: Find here all the highlights related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 16th October 2026. Sensex settled 413.66 pts or 0.56% higher at 74,729.27 on Friday, Nifty…

Receive a Daily briefing on Pharma Industry News

Get Started